LG and Mochida strike secretive biosimilars alliance
This article was originally published in Scrip
Executive Summary
In yet another example of Japan tapping into the more advanced expertise in the sector of its neighbor South Korea, Mochida and LG Life Sciences (LGLS) have entered into an agreement for the co-development and co-commercialization of biosimilars in the two countries.